| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP002758 |
|
171596-29-5 |
Tadalafil - 97.5~102.5% |
0 | C22H19N3O4 | |
| CP001174 |
|
80621-81-4 |
Rifaximin - 99% |
0 | C43H51N3O11 | |
| CP005102 |
|
81403-80-7 |
Alfuzosin - 98% |
0 | C19H27N5O4 | |
| CP005305 |
|
75498-96-3 |
Cefminox sodium - 91.0% |
0 | C16H20N7NaO7S3 | |
| CP002175 |
|
7683-59-2 |
Isoproterenol - 98% |
0 | C11H17NO3 | |
| CP000054 |
|
169590-42-5 |
Celecoxib - 98.0~102.0% |
0 | C17H14F3N3O2S | |
| CP008332 |
|
83105-70-8 |
Sultamicillin Tosylate - 98% |
0 | C25H30N4O9S2.C7H8O | |
| CP007190 |
|
32980-71-5 |
Perchloropyrimido[5,4-d]pyrimidine - |
0 | C6CL4N4 | |
| CP003766 |
|
109581-93-3 |
Tacrolimus monohydrate - 99% |
0 | C44H69NO12.H2O | |
| CP000933 |
|
584-08-7 |
Potassium carbonate - 98% |
0 | CK2O3 | |
| CP006810 |
|
130-37-0 |
Menadione sodium bisulfite - 98% |
0 | C11H10O5S.C6H6N2O | |
| CP006050 |
|
75706-12-6 |
5-METHYLISOXAZOLE-4-(4-TRIFLUOROMETHYLCARBOXANILIDE) - 98.0 ~ 102.0% |
0 | C12H9F3N2O2 | |
| CP006563 |
|
626-64-2 |
Pyridin-4-ol - 98% |
0 | C5H5NO | |
| CP005450 |
|
137330-13-3 |
Tilmicosin phosphate - 98% |
0 | C46H80N2O13.H3O4P | |
| CP007874 |
|
130-40-5 |
Riboflavin sodium phosphate;Riboflavin 5'-Monophosphate Sodium Salt - 73-79% |
0 | C17H20N4NAO9P.2H2O | |
| CP005113 |
|
1184-16-3 |
Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), 5'→5'-ester with 3-(aminocarbonyl)-1-β-d-ribofuranosylpyridinium hydroxide, inner salt, monosodium salt - 98% |
0 | C21H28N7O17P3.NA | |
| CP001357 |
|
625115-55-1 |
Riociguat - 99% |
0 | C20H19FN8O2 | |
| CP003714 |
|
766-55-2 |
Imidazo[1,2-b]pyridazine - 98% |
0 | C6H5N3 | |
| CP003905 |
|
2068-78-2 |
Vincristine sulfate - 95-105% |
0 | C46H58N4O14S | |
| CP001746 |
|
106861-44-3 |
Mivacurium chloride - ≥98.5% |
0 | C58H80CL2N2O14 | |